Biolexis, 7% 7aug2026, INR (Conv.) (INE0QCF08024)
国内債券, 転換社債, Senior Unsecured
国内債券, 転換社債, Senior Unsecured
|
Biolexis Private Limited was incorporated on 17 January, 2022. It is a wholly-owned subsidiary of Stelis Biopharma Limited. The company develops advanced biosimilars, peptides, and vaccines
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡